Trovagene Inc (TROV.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
- BRIEF-Trovagene Reports Q4 Loss Per Share $0.06
- BRIEF-Trovagene Announces Activation Of Two Additional Clinical Trial Sites To Conduct Early Stage Leukemia Study
- BRIEF-Trovagene Completes Cycle-One Dosing In First Patient Enrolled In Phase 1B/2 Clinical Trial Of PCM-075
- BRIEF-Trovagene Initiates Unite Phase 2 Clinical Trial Of PCM-075 In Patients With Metastatic Castration-Resistant Prostate Cancer
- BRIEF-Trovagene Announces Activation Of Second Clinical Trial Site In Phase 1B/2 Acute Myeloid Leukemia Trial